Allied Market Research
Upcoming Allied Market Research
Breast Cancer Drugs Market

Breast Cancer Drugs Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

Pages: NA
Dec 2021 | 386 Views
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Breast Cancer Drugs Market

Request Now !

The global Breast Cancer Drugs market is experiencing a significant growth, and will grow considerably in the next few years. Breast Cancer is a type of cancer wherein there is abnormal growth of the cells, which starts in the breast. It is mainly found in women, but is observed in men too. Breast cancer drugs are all those medications that are either involved in the prevention or treatment of cancer caused due to carcinogen formed in the area. There are various drugs that are used in combinations for the treatment of the breast cancer and are necessary to be approved by the Food and Drug Administration (FDA). Rise in incidences of breast cancer is anticipated to help the market flourish in the coming years. The chemotherapy is the most common therapy given for the cancer treatment. This targets the cells that are carcinogenic at different phases of life cycle and hence, helps cure the disease. The mechanism of action carried out by the drugs used for the disease include prevention of mutagenic initiation of carcinogenic process or prevention of the further progression of the lesion using suppressive agents.

Market scope and structure analysis:

Report Metric


  Market size available for years


  Base year considered


  Forecast period


  Forecast units

  Value (USD)

  Segments covered

  Drug Types and Region

  Regions covered

North America (U.S. and Canada), Europe (Germany, UK, France, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America (Brazil, Mexico, and the Rest of LATAM) and The Middle East and Africa

  Companies covered

Major players analyzed include Pfizer Inc., Novartis AG, Celgene Corporation, Merck and Co Inc., Janssen Global Services LLC, AbbVie, Inc., AstraZeneca, Genzyme Corporation, and F. Hoffman-La Roche Pvt. Ltd.

COVID-19 scenario analysis:

The outbreak of the pandemic situation led to a steep decrement in the revenue generation throughout the different countries. The global lockout has led to the downfall of the production of various medications which otherwise was at a higher rate. However, the healthcare professionals are now focusing on the methods to combat with the COVID-19 virus. The use of medications such as Hydrochloroquine which is observed to be potential drug is used for the management of the corona virus -2. The key market players who are producing the drug and the kits for diagnosis are expected to gain maximum shares in the current situation. The government is taking initiatives to combat with the current pandemic by investing more over the R&D of various drugs and the reagents that can be used to diagnose corona-virus.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The global breast cancer drugs market is expected to witness lucrative growth in the coming years. The major factor that is anticipated to propel the industry includes the increase in the incidences of the breast cancer. Furthermore, the rising concerns for effective treatment and management of the disease. Moreover, the rise in R&D of the novel drugs for the treatment of breast cancer would help the market grow in the near future. Additionally, the key market players are focusing on higher investments on the innovation and research and hence, increase the pipeline of drugs for breast cancer treatment. However, the stringent regulations of the government and expiry of the patented drugs may hinder the growth of the industry in the forecast period.

The global breast cancer drugs market trends are as follows:

New product launches to flourish the market

The key leaders are focusing over R&D of the products that are clinically useful for breast cancer. The growing innovation over the breast cancer drugs is expected to propel the industry in the near future. Furthermore, the launch of new products in the industry would help the market at a higher pace. For instance, in April 2020, U.S. Food and Drug Association approved tucatinib, also called as Tukysa, which can be given in combination with advanced form of the chemotherapy drugs capecitabine and trastuzumab. This combination was approved for the treatment of adult patients with advanced form of HER2 – positive breast cancer, which is not removable using surgery.

Furthermore, there is a higher competition in the key market players to bring up belter versions of the medications for the cure of breast cancer. For instance, in Feb 2020, AZ and Daiichi got an approval to market Enhertu, which is approved for its function to treat third line HER2-positive breast cancer patients. The rise in the number of product launches in the recent years would gain attention of the individuals for breast cancer diagnosis and hence, boost the industry in the forecast period.

Rise in incidences of breast cancer boosting demand for drugs

The steep rise in the number of women who are experiencing breast cancer across the globe are anticipated to propel the industrial growth in the coming years. According to the statistics claimed by the World Health Organization in 2018, the incidence of breast cancer is observed to be impacting about 2.1 million women every year. Furthermore, the total deaths are estimated to be 627,000 women experiencing breast cancer, which accounts to about 15% of all cancer deaths in women.

Additionally, the parameter of age is also held responsible for the incidence of cancer. The proportionality of age is estimated to be equal with the rate of incidences or occurrences of cancer in the individuals. In addition, risk factors associated with the breast cancer include misuse of the oral contraceptives, reduction in the duration of breast feeding, and hike in the treatment taken for estrogen modification. These risk factors if not controlled may result into the higher susceptibility of the individual to experience breast cancer. The surge in the inclination toward unhealthy lifestyle such as consumption of oily food, and high salt concentration food would lead to obesity and is a major risk factor for breast cancer. This would help the industry grow at a significant rate in the near future.

Key segments covered:



  Drug Type

  • Targeted Therapy Drugs
  • Tyrosine Kinase Inhibitors
  • Monoclonal Antibodies
  • Trastuzumab
  • Bevacizumab
  • Others
  • Hormone Therapy Drugs
  • Selective Estrogen Receptor Modulators (SERMs)
  • Raloxifen
  • Toremifene
  • Tamoxifen
  • Aromatase Inhibitors
  • Megestrol
  • Anastrozole
  • Letrozole
  • Other Hormonal Therapies
  • Fulvestrant
  • Fluoxymesterone
  • Gosereline Acetate
  • Chemotherapy Drugs
  • Taxanes
  • Docetaxel
  • Paclitaxel
  • Anthracyclines
  • Epirubicin
  • Doxorubicin
  • Antimetabolites
  • Gemcitabine
  • Capecitabine
  • Fluorouracil
  • Epithilones
  • Alkylating Agents

Key benefits of the report:

  • This study presents the analytical depiction of the global breast cancer drugs industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global breast cancer drugs market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the breast cancer drugs market research report:

  • Who are the leading market players active in the breast cancer drugs market?
  • What are the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

Toll-free :
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email :
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.










Purchase Full Report of
Breast Cancer Drugs Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $9,995  $8,996
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers